Babich, John W.,Zimmerman, Craig N.,Joyal, John,Lu, Genliang
申请号：
HUE17187271
公开号：
HUE044552T2
申请日:
2014.01.10
申请国别(地区):
HU
年份:
2019
代理人:
摘要：
Compounds according to Formula I and Formula II are potent inhibitors of PSMA. or Pharmaceutical compositions may include a complex of a radionuclide and a Formula I compound or a Formula II compound. Methods include using the radionuclide complex of a Formula I compound or a Formula II compound for treating or diagnosis of a disease or a condition associated with PSMA activity.
